Cowealth Medical Holding Co., Ltd. (4745.TWO)
TWD 20.5
(-0.97%)
TWD 20.5
(-0.97%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 45.02 Million | -267.59 Million | -118.37 Million | 804.75 Million | - |
| Net Income | 270.31 Million | 388.34 Million | 334.73 Million | 314.93 Million | - |
| Depreciation & Amortization | 55.03 Million | 57.28 Million | 69.85 Million | 108.01 Million | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -153.67 Million | -624.86 Million | -415.39 Million | 352.16 Million | - |
| Other non-cash items | 27.72 Million | -6.78 Million | 18.89 Million | 25.97 Million | - |
| Investing Cash Flow | -173.27 Million | -270.99 Million | -13.51 Million | 357.07 Million | - |
| Investments in PPE | -236.49 Million | -26.37 Million | -36.66 Million | -28.08 Million | - |
| Acquisitions | -109.72 Million | - | - | - | -3.82 Million |
| Investment purchases | - | -253.93 Million | 7.2 Million | 317.93 Million | - |
| Sales/Maturities of investments | 113.23 Million | - | 7.2 Million | 57.04 Million | - |
| Other Investing Activities | -50.78 Million | 7.92 Million | 15.8 Million | -20.49 Million | - |
| Financing Cash Flow | -316.48 Million | 1.06 Billion | -198.55 Million | -280.98 Million | - |
| Debt repayment | -30.32 Million | -234.89 Million | -67.56 Million | -146.33 Million | - |
| Dividends payments | -123.92 Million | -116.17 Million | -92.93 Million | -88.51 Million | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 1.45 Billion | - | - | - |
| Other Financing Activities | -110.11 Million | 1.45 Billion | - | - | 1.22 Billion |
| Accounts receivables | 30.6 Million | - | - | - | - |
| Accounts payables | -65.76 Million | - | - | - | - |
| Inventory | 35.72 Million | -53.78 Million | -186.68 Million | -172.05 Million | - |
| Other working capital | -220 Million | - | - | - | - |
| Cash at beginning of period | 1.38 Billion | 842.68 Million | 1.21 Billion | 327.23 Million | - |
| Cash at end of period | 834.72 Million | 1.38 Billion | 842.68 Million | 1.21 Billion | - |
| Capital Expenditure | -236.49 Million | -26.37 Million | -36.66 Million | -28.08 Million | - |
| Effect of forex changes on cash | -103.92 Million | 13.21 Million | -38.03 Million | 3.08 Million | - |
| Net cash flow / Change in cash | -548.66 Million | 540.7 Million | -368.48 Million | 883.92 Million | - |
| Free Cash Flow | -191.47 Million | -293.96 Million | -155.03 Million | 776.67 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.03 Million | 36.96 Million | 270.31 Million | 38.22 Million | 54.08 Million | 107.4 Million |
| Depreciation & Amortization | 11.78 Million | 13.29 Million | 55.03 Million | 13.08 Million | 13.43 Million | 16.04 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 55.73 Million | -432.14 Million | -153.67 Million | 241.03 Million | -16.71 Million | 254.32 Million |
| Other non-cash items | 6.12 Million | 6.18 Million | 27.72 Million | 4.4 Million | 11.91 Million | 13.39 Million |
| Investing Cash Flow | -25.61 Million | 103.73 Million | -173.27 Million | -198.42 Million | -29.67 Million | -31.46 Million |
| Investments in PPE | -40.23 Million | -12.47 Million | -236.49 Million | -216.93 Million | -1.41 Million | -7.65 Million |
| Acquisitions | -46.43 Million | - | - | - | - | - |
| Investment purchases | - | -2.57 Million | - | - | - | -40.65 Million |
| Sales/Maturities of investments | 13.06 Million | 93.65 Million | 113.23 Million | 5.1 Million | 1.98 Million | 49.21 Million |
| Other Investing Activities | -1.03 Million | 24.9 Million | -50.78 Million | 13.08 Million | -30.3 Million | -32.66 Million |
| Financing Cash Flow | -206.56 Million | 247.13 Million | -316.48 Million | -475.66 Million | -248.74 Million | 233.37 Million |
| Debt repayment | -152.64 Million | -257.67 Million | -30.32 Million | -466.26 Million | -107.86 Million | -357.31 Million |
| Dividends payments | - | - | -123.92 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -46.44 Million | 9000.00 | -110.11 Million | -227 Thousand | 16 Thousand | -110.64 Million |
| Accounts receivables | -69.7 Million | - | - | - | - | - |
| Accounts payables | 135.32 Million | - | - | - | - | - |
| Inventory | 7.54 Million | -24.41 Million | 35.72 Million | 18.39 Million | -3.61 Million | 17.26 Million |
| Other working capital | -17.44 Million | - | - | - | - | - |
| Cash at beginning of period | 922.41 Million | 834.72 Million | 1.38 Billion | 1.36 Billion | 1.46 Billion | 1.08 Billion |
| Cash at end of period | 793.74 Million | 922.41 Million | 834.72 Million | 834.72 Million | 1.36 Billion | 1.46 Billion |
| Capital Expenditure | -40.23 Million | -12.47 Million | -236.49 Million | -216.93 Million | -1.41 Million | -7.65 Million |
| Effect of forex changes on cash | 47.52 Million | 109.31 Million | -103.92 Million | -108.28 Million | 129.53 Million | -151.86 Million |
| Net cash flow / Change in cash | -128.67 Million | 87.68 Million | -548.66 Million | -527.05 Million | -103.38 Million | 382.53 Million |
| Free Cash Flow | 15.74 Million | -384.97 Million | -191.47 Million | 38.38 Million | 44.08 Million | 324.82 Million |
GRBMF
000651
6AX
SNNUF
8096
CLLS